{
    "2019-09-09": [
        [
            {
                "time": "",
                "orginal_text": "中信建投医药 | 行业周报】业绩真空期，继续配置高性价比品种",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "行业周报",
                        "业绩真空期",
                        "高性价比"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "三个月千亿外资已入场，扫货消费、科技，42股买入超2%",
                "features": {
                    "keywords": [
                        "外资",
                        "入场",
                        "消费",
                        "科技",
                        "买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "基石药业3年半亏损超36亿 抗癌神药如何破解价格战 亏损",
                "features": {
                    "keywords": [
                        "基石药业",
                        "亏损",
                        "抗癌神药",
                        "价格战"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德(02359-HK)回购合计338,349股限制性A股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "回购",
                        "限制性A股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药行业周报: 病理免疫组化为被市场遗忘的“小化学发光”",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "病理免疫组化",
                        "小化学发光"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}